Related Experiment Videos
Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome
Insights
Investigating serotonin (5-hydroxytryptamine or 5-HT) levels in children with Hemolytic Uremic Syndrome (HUS) revealed low 5-HT during acute illness, suggesting platelet issues. Normal levels post-HUS indicate full recovery.
Area of Science:
- Pediatric Nephrology
- Hematology
- Clinical Chemistry
Background:
- Hemolytic Uremic Syndrome (HUS) is a serious condition affecting children, often involving kidney damage.
- Platelet aggregation and serotonin (5-hydroxytryptamine or 5-HT) metabolism are implicated in HUS pathogenesis.
- Assessing recovery and long-term prognosis in HUS requires reliable biomarkers.
Purpose of the Study:
- To investigate the role of 5-HT levels in children diagnosed with HUS.
- To determine if 5-HT levels can serve as an indicator of disease activity and recovery in HUS.
- To explore the correlation between 5-HT levels, renal pathology, and clinical outcomes in pediatric HUS.
Main Methods:
- Serotonin (5-HT) levels were measured in 14 children with HUS.
- Blood samples were analyzed during the acute phase of HUS and at a 3-month follow-up.
- Renal biopsies were performed to assess histopathological changes, including thrombotic microangiopathy and glomerular involvement.
Main Results:
- All children exhibited low 5-HT levels during the acute phase of HUS, consistent with platelet aggregation and degranulation.
- Three months post-HUS, children with chronic renal failure and cortical necrosis showed persistent low 5-HT levels.
- Children who fully recovered from HUS, with predominantly glomerular thrombotic microangiopathy, presented with normal 5-HT levels.
Conclusions:
- Normal 5-HT levels following the acute stage of HUS are a strong indicator of complete clinical recovery.
- Low 5-HT levels in the chronic phase may signify ongoing renal damage or incomplete recovery in HUS patients.
- Further research is needed to establish the prognostic significance of persistent low 5-HT levels in children with chronic renal failure secondary to HUS.
Abstract:
I5HT levels were investigated in 14 children with Hemolytic Uremic Syndrome (HUS). Low levels of I5HT were demonstrated in all the children studied during the early phase of the disease, indicating reversible platelet aggregation and recirculation of degranulated platelets. Three months after the onset of HUS, only 2 children with a pathological picture of cortical necrosis and a mild degree of chronic renal failure had low I5HT levels. On the contrary, normal I5HT levels were present in the other children completely recovered from HUS and with a renal biopsy picture of thrombotic microangiopathy with predominant glomerular involvement. We conclude that normal values of I5HT, after the acute stage of HUS, are a good index of complete recovery from the disease. Further observations are required to assess the prognostic value of low I5HT levels in children with chronic renal failure secondary to HUS.